{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:04:31Z","timestamp":1789661071382,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_21040"],"award-info":[{"award-number":["MC_PC_21040"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000294","name":"Medical Research Scotland","doi-asserted-by":"publisher","award":["PhD-50695-2023"],"award-info":[{"award-number":["PhD-50695-2023"]}],"id":[{"id":"10.13039\/501100000294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.chembiol.2026.08.006","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:46:39Z","timestamp":1788273999000},"page":"1333-1341.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncogene activation mechanism determines the limits of targeted protein degradation"],"prefix":"10.1016","volume":"33","author":[{"given":"Evelina","family":"Gudauskait\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianda","family":"Hern\u00e1ndez-Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian C.A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0653-2070","authenticated-orcid":false,"given":"Andrew J.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2026.08.006_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2026.08.006_bib2","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"Phthalimide conjugation as a strategy for in vivo target protein degradation","volume":"348","author":"Winter","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2026.08.006_bib3","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","article-title":"Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4","volume":"10","author":"Zengerle","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2026.08.006_bib4","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: Chimeric molecules that target proteins to the Skp1\u2013Cullin\u2013F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2026.08.006_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","article-title":"Targeted protein degradation for cancer therapy","volume":"25","author":"Hinterndorfer","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.chembiol.2026.08.006_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cancers17050785","article-title":"KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy","volume":"17","author":"Uniyal","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.chembiol.2026.08.006_bib7","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/onc.2008.98","article-title":"DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers","volume":"27","author":"Lockwood","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2026.08.006_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41568-019-0128-6","article-title":"Extrachromosomal oncogene amplification in tumour pathogenesis and evolution","volume":"19","author":"Verhaak","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.chembiol.2026.08.006_bib9","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/ng.465","article-title":"SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas","volume":"41","author":"Bass","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2026.08.006_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aak9982","article-title":"Degrons in cancer","volume":"10","author":"M\u00e9sz\u00e1ros","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.chembiol.2026.08.006_bib11","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1038\/s41467-021-26871-y","article-title":"Genetic fusions favor tumorigenesis through degron loss in oncogenes","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.08.006_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2017.00085","article-title":"The KEAP1\u2013NRF2 System in Cancer","volume":"7","author":"Taguchi","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.chembiol.2026.08.006_bib13","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.18632\/oncotarget.3377","article-title":"Multiple mechanisms of MYCN dysregulation in Wilms tumour","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2026.08.006_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ccr.2008.12.005","article-title":"Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma","volume":"15","author":"Otto","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2026.08.006_bib15","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1039\/D2CS00114D","article-title":"Translational PK\u2013PD for targeted protein degradation","volume":"51","author":"Bartlett","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.chembiol.2026.08.006_bib16","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1021\/acschembio.4c00152","article-title":"Confounding Factors in Targeted Degradation of Short-Lived Proteins","volume":"19","author":"Vetma","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2026.08.006_bib17","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1021\/acschembio.8b00692","article-title":"Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action","volume":"13","author":"Riching","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2026.08.006_bib18","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41467-019-09358-9","article-title":"Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction","volume":"10","author":"Simonetta","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.08.006_bib19","doi-asserted-by":"crossref","first-page":"16856","DOI":"10.1021\/jacs.4c05174","article-title":"Covalent Degrader of the Oncogenic Transcription Factor \u03b2-Catenin","volume":"146","author":"Gowans","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2026.08.006_bib20","article-title":"Positive Selection Screen for Natural Product \u03b2-Catenin Inactivators","volume":"2025","author":"Boudreau","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.chembiol.2026.08.006_bib21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41588-025-02496-5","article-title":"Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signaling","volume":"58","author":"Krishna","year":"2026","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2026.08.006_bib22","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","article-title":"Activation of \u03b2-Catenin-Tcf Signaling in Colon Cancer by Mutations in \u03b2-Catenin or APC","volume":"275","author":"Morin","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2026.08.006_bib23","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","article-title":"Constitutive Transcriptional Activation by a \u03b2-Catenin-Tcf Complex in APC\u2212\/\u2212 Colon Carcinoma","volume":"275","author":"Korinek","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2026.08.006_bib24","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.28638","article-title":"Genotype-phenotype correlation of CTNNB1 mutations reveals different \u00df-catenin activity associated with liver tumor progression","volume":"64","author":"Rebouissou","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.chembiol.2026.08.006_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41589-018-0021-8","article-title":"The dTAG system for immediate and target-specific protein degradation","volume":"14","author":"Nabet","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2026.08.006_bib26","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1038\/s41467-020-18377-w","article-title":"Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules","volume":"11","author":"Nabet","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.08.006_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011830","article-title":"Tissue-specific consequences of tag fusions on protein expression in transgenic mice","volume":"21","author":"Taylor","year":"2025","journal-title":"PLoS Genet."},{"key":"10.1016\/j.chembiol.2026.08.006_bib28","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.18632\/oncotarget.23695","article-title":"Exon 3 mutations of CTNNB1 drive tumorigenesis: a review","volume":"9","author":"Gao","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2026.08.006_bib29","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-Catenin Signaling and Disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2026.08.006_bib30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64498","article-title":"Allele-specific endogenous tagging and quantitative analysis of \u03b2-catenin in colorectal cancer cells","volume":"11","author":"Ambrosi","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.chembiol.2026.08.006_bib31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41556-022-00913-z","article-title":"Pan-cancer pervasive upregulation of 3\u2032 UTR splicing drives tumourigenesis","volume":"24","author":"Chan","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.chembiol.2026.08.006_bib32","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","article-title":"\u03b2-catenin is a target for the ubiquitin\u2013proteasome pathway","volume":"16","author":"Aberle","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2026.08.006_bib33","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.devcel.2021.07.009","article-title":"Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies","volume":"56","author":"Lukow","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.chembiol.2026.08.006_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41573-025-01369-0","article-title":"Targeting extrachromosomal DNA in human cancers","volume":"25","author":"Wong","year":"2026","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2026.08.006_bib35","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng.2760","article-title":"Pan-cancer patterns of somatic copy number alteration","volume":"45","author":"Zack","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2026.08.006_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.06.003","article-title":"Imatinib resistance in CML","volume":"274","author":"Volpe","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.chembiol.2026.08.006_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001148","article-title":"BRAF Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation","volume":"3","author":"Corcoran","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.chembiol.2026.08.006_bib38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.devcel.2018.10.027","article-title":"A Cell\/Cilia Cycle Biosensor for Single-Cell Kinetics Reveals Persistence of Cilia after G1\/S Transition Is a General Property in Cells and Mice","volume":"47","author":"Ford","year":"2018","journal-title":"Dev. Cell"},{"key":"10.1016\/j.chembiol.2026.08.006_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146021","article-title":"Dose-Response Analysis Using R","volume":"10","author":"Ritz","year":"2015","journal-title":"PLoS One"}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245194562600293X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245194562600293X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:16:08Z","timestamp":1789658168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S245194562600293X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S245194562600293X"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2026.08.006","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncogene activation mechanism determines the limits of targeted protein degradation","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2026.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}